losartan has been researched along with 8-bromo cyclic adenosine monophosphate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanehira, T; Kano, H; Kohno, M; Minami, M; Yasunari, K; Yokokawa, K; Yoshikawa, J | 1 |
Chatterjee, PK; Hawksworth, GM; McLay, JS; Mistry, SK; Weerackody, RP | 1 |
2 other study(ies) available for losartan and 8-bromo cyclic adenosine monophosphate
Article | Year |
---|---|
Adrenomedullin is a potent inhibitor of angiotensin II-induced migration of human coronary artery smooth muscle cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenomedullin; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Cell Movement; Cells, Cultured; Coronary Vessels; Dose-Response Relationship, Drug; Humans; Imidazoles; Losartan; Muscle, Smooth, Vascular; Peptides; Tetrazoles; Vasodilator Agents | 1997 |
Selective antagonism of the AT1 receptor inhibits angiotensin II stimulated DNA and protein synthesis in primary cultures of human proximal tubular cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cells, Cultured; DNA; Humans; Imidazoles; Kidney Tubules, Proximal; Losartan; Protein Biosynthesis; Pyridines; Tetrazoles | 1997 |